<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02427256</url>
  </required_header>
  <id_info>
    <org_study_id>TOPCON-SP-1P-US-0002</org_study_id>
    <nct_id>NCT02427256</nct_id>
  </id_info>
  <brief_title>Second Comparative Study of Specular Microscopes for Endothelial and Corneal Cell Measurements</brief_title>
  <official_title>Comparative Study of the Topcon Specular Microscope SP-1P and the Konan Specular Microscope CELLCHEK XL (Predicate Device) for the Measurements of Endothelial Cell Density Measurements, Coefficient of Variation of Endothelial Cell Area, ％ Hexagonality, Central Corneal Thickness</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Topcon Medical Systems, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Topcon Medical Systems, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this clinical study is to collect additional clinical data to
      support an FDA 510(k) submission for the Topcon Specular Microscope SP-1P. The secondary
      objective is to evaluate any adverse events found during the clinical study.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2015</start_date>
  <completion_date type="Actual">February 2015</completion_date>
  <primary_completion_date type="Actual">February 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Corneal endothelial cell density</measure>
    <time_frame>Single time point - 1 day</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Coefficient of variation of endothelial cell area</measure>
    <time_frame>Single time point - 1 day</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Corneal endothelial cell % hexagonality</measure>
    <time_frame>Single time point - 1 day</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Central corneal thickness</measure>
    <time_frame>Single time point - 1 day</time_frame>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">76</enrollment>
  <condition>Corneal Endothelial Cell Loss</condition>
  <arm_group>
    <arm_group_label>Non-Pathologic Adults age 18-28 yrs</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-Pathologic Adults age 29-80 yrs</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Pathologic Adults age 29-80 yrs</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Device: Topcon Specular Microscope SP-1P</intervention_name>
    <description>Device: Topcon Specular Microscope SP-1P</description>
    <arm_group_label>Non-Pathologic Adults age 18-28 yrs</arm_group_label>
    <arm_group_label>Non-Pathologic Adults age 29-80 yrs</arm_group_label>
    <arm_group_label>Pathologic Adults age 29-80 yrs</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Ophthalmology Practice
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria － Non-Pathologic Young Adults (18-28 years old) and Non-Pathologic
        Adults (29-80 years old):

          -  Male or female subjects from 18 to 80 years old who have full legal capacity to
             volunteer on the date the informed consent is signed;

          -  Subjects who can follow the instructions by the clinical staff at the clinical site,
             and can attend examinations on the scheduled examination date;

          -  Subjects who agree to participate in the study.

        Inclusion Criteria － Pathologic Adults (29-80 years old)

          -  Male and female subjects from 29 to 80 years old who have full legal capacity to
             volunteer on the date the informed consent is signed;

          -  Subjects who can follow the instructions by the clinical staff at the clinical site,
             and can attend examinations on the scheduled examination date;

          -  Subjects who agree to participate in the study;

          -  At least one eye with any of the following conditions:

          -  History of post-op surgical trauma including Pseudophakic or Aphakic bullous
             keratopathy;

          -  History of corneal transplant;

          -  Physical injury or trauma to the cornea;

          -  Long term Fuch's dystrophy, Guttata, or other corneal endothelial dystrophies

          -  Keratoconus;

          -  Long term polymethyl methacrylate PMMA contact lens use (greater than 3 years).

        Exclusion Criteria － Non-Pathologic Young Adults (18-28 years old) and Non Pathologic
        Adults (29-80 years old)

          -  History of post-op surgical trauma including bullous keratopathy;

          -  History of corneal transplant;

          -  Evidence of physical injury or trauma to the cornea;

          -  Long term Fuch's dystrophy, Guttata or other corneal endothelial dystrophies;

          -  Keratoconus;

          -  Long term PMMA contact lens use (greater than 3 years);

          -  History of cataract, refractive or ocular surgical procedures that render the cornea
             opaque or otherwise impact its ability to be imaged using the investigational device;

          -  Fixation problems which may prevent obtaining good quality SP-1P and CELLCHEK PLUS in
             either eye.

        Exclusion Criteria － Pathologic Adults (29-80 years old):

          -  History of cataract, refractive or ocular surgical procedures that render the cornea
             opaque or otherwise impact its ability to be imaged using the investigational device;

          -  Fixation problems which may prevent obtaining good quality SP-1P and CELLCHEK PLUS in
             either eye.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Andover Eye Associates</name>
      <address>
        <city>Andover</city>
        <state>Massachusetts</state>
        <zip>01810</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 22, 2015</study_first_submitted>
  <study_first_submitted_qc>April 22, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 27, 2015</study_first_posted>
  <last_update_submitted>December 1, 2015</last_update_submitted>
  <last_update_submitted_qc>December 1, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 2, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Corneal Endothelial Cell Loss</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

